Indication
Mononegavirales Infections
2 clinical trials
4 products
Clinical trial
A Phase III Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies in Adults With Category III Rabies Exposure RisksStatus: Completed, Estimated PCD: 2022-06-24
Product
SYN023Product
Human Rabies Immune GlobulinProduct
Rabies VaccineClinical trial
A Phase 2, Open-label, Study to Evaluate the Safety and Immunogenicity of a Heterologous 2-dose Vaccination Regimen Using Ad26.ZEBOV, MVA-BN-Filo in Adults and Children Originally Enrolled in the Control Arm of the EBOVAC-Salone StudyStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Product
Ad26.ZEBOV, MVA-BN-Filo